Macquarie Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $132M | Sell |
|
|||||
|
2025
Q2 | $119M | Buy |
|
|||||
|
2025
Q1 | $114M | Buy |
|
|||||
|
2024
Q4 | $81.6M | Sell |
|
|||||
|
2024
Q3 | $89.4M | Sell |
|
|||||
|
2024
Q2 | $86.4M | Buy |
|
|||||
|
2024
Q1 | $55.9M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Buy |
|
|||||
|
2023
Q3 | $1.5M | Sell |
|
|||||
|
2023
Q2 | $3.31M | Buy |
|
|||||
|
2023
Q1 | $1.23M | Buy |
|
|||||
|
2022
Q4 | $1.42M | Sell |
|
|||||
|
2022
Q3 | $1.24M | Sell |
|
|||||
|
2022
Q2 | $1.31M | Sell |
|
|||||
|
2022
Q1 | $1.63K | Buy |
|
|||||
|
2021
Q4 | $994K | Buy |
|
|||||
|
2021
Q3 | $865K | Buy |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2021
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | $1.54M | Buy |
|
|||||
|
2020
Q3 | $83K | Hold |
|
|||||
|
2020
Q2 | $96K | Buy |
|